When and what imaging should be performed after Penumbra mechanical thrombectomy for acute submassive pulmonary embolism (PE) and deep vein thrombosis (DVT)?

Post-Penumbra Mechanical Thrombectomy Imaging Protocol for Acute Submassive PE and DVT

Routine follow-up imaging is not recommended in asymptomatic patients after mechanical thrombectomy for submassive PE, but clinical surveillance with focused assessment for persistent dyspnea, functional limitation, and signs of recurrence should be performed at 3-6 months 1.

Immediate Post-Procedure Assessment

Within 24-48 Hours Post-Thrombectomy

• Transthoracic echocardiography to assess RV function and RV/LV ratio reduction

  • Target: RV/LV ratio should decrease from baseline (typically from ~1.7 to ~1.1)
  • TAPSE/sPAP ratio should improve to >0.31 mm/mmHg 2
  • This confirms immediate procedural success and hemodynamic improvement

• For DVT component: Lower extremity duplex ultrasound only if:

  • Persistent or worsening leg symptoms
  • Clinical signs of DVT progression
  • Otherwise, imaging is not routinely indicated 3

Short-Term Follow-Up (5-7 Days)

DVT-Specific Imaging

If the patient had concurrent DVT treated with thrombectomy:

• Repeat duplex ultrasound at 5-7 days if:

  • Initial study was technically limited
  • Isolated distal DVT was treated (to assess for proximal extension)
  • New or worsening leg symptoms develop 3

• No repeat imaging needed if:

  • Patient is asymptomatic
  • Initial complete duplex ultrasound was adequate
  • Patient is appropriately anticoagulated

Medium-Term Follow-Up (3 Months)

Clinical Assessment Priority

Focus on symptom-driven evaluation rather than routine imaging 1:

• Ask specifically about:
  • Persistent or new-onset dyspnea
  • Exercise intolerance or functional limitation
  • Chest pain with exertion
  • Signs of DVT recurrence (leg swelling, pain)

Imaging Indications at 3 Months

CT Pulmonary Angiography (CTPA) should be performed ONLY if:

• Patient reports persistent dyspnea or functional limitation (to evaluate for chronic thromboembolic pulmonary hypertension [CTEPH])
• Risk factors for CTEPH development are present
• Clinical deterioration occurs 1

Lower extremity duplex ultrasound if:

• Signs or symptoms of recurrent DVT
• Otherwise not routinely indicated 3

Echocardiography may be considered if:

• Persistent symptoms suggest ongoing RV dysfunction
• Concern for pulmonary hypertension
• Data shows continued hemodynamic improvement at 3 months with further PAP reduction 2

Long-Term Surveillance (Beyond 3 Months)

No Routine Imaging Protocol

The 2019 ESC guidelines explicitly state that follow-up imaging is not routinely recommended in asymptomatic patients 1. Instead:

• Clinical follow-up visits to assess for:

  • VTE recurrence symptoms
  • Bleeding complications from anticoagulation
  • Occult malignancy screening (if idiopathic VTE)
  • Functional status and quality of life

• Staged diagnostic workup only if symptomatic:

  • If dyspnea persists: CTPA and echocardiography to exclude CTEPH
  • If leg symptoms: duplex ultrasound
  • Consider cardiopulmonary exercise testing if functional limitation without clear imaging findings

Critical Caveats

When to Image More Aggressively

Consider earlier or more frequent imaging if:

• Bilateral extensive PE was present initially
• Massive thrombus burden despite thrombectomy
• Underlying malignancy (higher recurrence risk)
• Inadequate anticoagulation or contraindications to full anticoagulation
• May-Thurner syndrome or other anatomic compression syndromes requiring intervention 4

Common Pitfalls to Avoid

1. Do not order routine "surveillance" CTPA at fixed intervals (e.g., 1 month, 6 months) in asymptomatic patients—this exposes patients to unnecessary radiation and contrast without proven benefit 1

2. Do not rely on a single negative ultrasound to exclude subclinical DVT if clinical suspicion remains high 5

3. Do not delay anticoagulation while awaiting follow-up imaging—anticoagulation should be maintained per standard VTE protocols (minimum 3 months, often longer for unprovoked PE) 1, 6

4. Do not dismiss persistent symptoms—these warrant investigation for CTEPH, which develops in a subset of PE patients and requires specific diagnosis and treatment 1

Anticoagulation Monitoring Takes Priority

The most important "follow-up" is ensuring appropriate anticoagulation continuation and reassessment at 3-6 months to determine duration of therapy, not repeat imaging 1, 6. The decision to extend anticoagulation beyond 3-6 months should be based on recurrence risk versus bleeding risk, not imaging findings in asymptomatic patients.